Lisda Suteja
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 4
- Chemokine receptors and signaling 1
-
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
- Immune Cell Function and Interaction 2
- Immune cells in cancer 1
- Co-authors
- N. Gopalakrishna Iyer (6 shared papers)Daniel S.W. Tan (4 shared papers)Joe Yeong (3 shared papers)Wan‐Teck Lim (4 shared papers)Jerry Kok Yen Chan (2 shared papers)Constance H. Li (2 shared papers)Min Liu (2 shared papers)Wilson Wei Sheng Tan (2 shared papers)
- Journals
- Nature Communications (2 papers)Science Advances (1 paper)Cancer Immunology Immunotherapy (1 paper)Cancers (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- SingaporeUnited KingdomTaiwan
In The Last Decade
Lisda Suteja
6 papers receiving 213 citations
Peers
Comparison fields: 5 of 30
- Oncology 145
- Immunology 104
- Cancer Research 44
- Otorhinolaryngology 11
- Physiology 7
Countries citing papers authored by Lisda Suteja
This map shows the geographic impact of Lisda Suteja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisda Suteja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisda Suteja more than expected).
Fields of papers citing papers by Lisda Suteja
This network shows the impact of papers produced by Lisda Suteja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisda Suteja. The network helps show where Lisda Suteja may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisda Suteja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 65 | |
| 2 | 2021 | 52 | |
| 3 | 2022 | 32 | |
| 4 | 2020 | 32 | |
| 5 | 2023 | 25 | |
| 6 | 2021 | 8 | |
| 7 | 2025 | 0 |
About Lisda Suteja
Lisda Suteja is a scholar working on Oncology, Immunology, Molecular Biology, Otorhinolaryngology and Infectious Diseases, having authored 7 papers that have together received 214 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (2 papers), Immune Cell Function and Interaction (2 papers), Single-cell and spatial transcriptomics (1 paper), Immune cells in cancer (1 paper) and Chemokine receptors and signaling (1 paper). The work is most often cited by research in Oncology (145 citations), Immunology (104 citations), Cancer Research (44 citations), Otorhinolaryngology (11 citations) and Physiology (7 citations). Lisda Suteja has collaborated with scholars based in Singapore, United Kingdom and Taiwan. Frequent co-authors include N. Gopalakrishna Iyer, Daniel S.W. Tan, Joe Yeong, Wan‐Teck Lim, Jerry Kok Yen Chan, Constance H. Li, Min Liu, Wilson Wei Sheng Tan, Sue Yee Tan and Shilpi Gupta. Their work appears in journals such as Nature Communications, Science Advances, Cancer Immunology Immunotherapy, Cancers and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.